Similar articles

• Familial haemolytic uraemic syndrome and an MCP mutation.

  Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G; International Registry of Recurrent and Familial HUS/TTP. Noris M, et al. Lancet. 2003 Nov 8;362(9395):1542-7. doi: 10.1016/S0140-6736(03)14742-3. Lancet. 2003. PMID: 14615110
• Complement factor H and the haemolytic uraemic syndrome.

  Taylor CM. Taylor CM. Lancet. 2001 Oct 13;358(9289):1200-2. doi: 10.1016/s0140-6736(01)06339-5. Lancet. 2001. PMID: 11675053 No abstract available.
• Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?

  Noris M, Remuzzi G. Noris M, et al. Nat Clin Pract Nephrol. 2005 Nov;1(1):2-3. doi: 10.1038/ncpneph0018. Nat Clin Pract Nephrol. 2005. PMID: 16932353 No abstract available.
• [Complement regulatory proteins].

  Miyagawa S. Miyagawa S. Nihon Rinsho. 2005 Apr;63 Suppl 4:274-8. Nihon Rinsho. 2005. PMID: 15861668 Review. Japanese. No abstract available.
• The regulation of the complement system: insights from genetically-engineered mice.

  Turnberg D, Botto M. Turnberg D, et al. Mol Immunol. 2003 Sep;40(2-4):145-53. doi: 10.1016/s0161-5890(03)00110-x. Mol Immunol. 2003. PMID: 12914820 Review.